Company: BDRX
Filing Date: 2025-09-26
Form Type: F-3
Source: 0001214659-25-014255
Chunk: 0

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-09-26
Form: F-3
Chunk 0
---
<div align='center'>As filed with the Securities and Exchange Commission on September 26, 2025</div>

Registration No. 333-

<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form F-3

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

BIODEXA PHARMACEUTICALS PLC

(Exact name of registrant as specified in its charter)

Not Applicable

(Translation of registrant’s name into English)</div>

| England and Wales               | Not Applicable        |
| (State or other jurisdiction of 
 incorporation or organization)  | -I.R.S. Employer      
 Identification Number |

<div align='center'>1 Caspian Point

Caspian Way

Cardiff, CF10 4DQ

United Kingdom

Telephone: +44 29 2048 0180

(Address and telephone number of registrant’s
principal executive offices)

Donald J. Puglisi

Puglisi & Associates

850 Library Avenue, Suite 204

Newark, DE

Telephone: (302) 738-6680

(Name, address, and telephone number of agent for
service)

Copies to:

Jason S. McCaffrey, Esq.

Mintz, Levin, Cohn, Ferris, Glovsky and

Popeo, P.C.

One Financial Center

Boston, MA 02111

Telephone: (617) 542-6000

Facsimile: (617) 542-2241</div>

APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:From time to time after the effective date of this registration statement.

If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the following box. ¨

If any of the securities being registered on this Form are to be offered
on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection
with dividend or interest reinvestment plans, check the following box. x

If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number
of the earlier effective registration statement for the same offering. ¨